The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study.

Cara De Galan,Marie Truyens,Harald Peeters,Francisco Mesonero Gismero,Ainara Elorza,Paola Torres,Liv Vandermeulen,Aranzazu Jauregui Amezaga,Rocio Ferreiro-Iglesias,Tom Holvoet,Yamile Zabana,Laia Peries Reverter,Gerard Bryan Gonzales,Jeroen Geldof,Gaëlle Varkas,Martine De Vos,Triana Lobatón

Journal of Crohn's & colitis（2022）

引用 6|浏览22

暂无评分

摘要

Vedolizumab and ustekinumab can be used safely in patients with articular extra-intestinal manifestations. Only a temporary increased risk for developing arthralgia has been observed under vedolizumab.

查看译文

关键词

Spondyloarthropathy,biologicals,inflammatory bowel disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要